Professional Documents
Culture Documents
1 s2.0 S0923250819300373 Main
1 s2.0 S0923250819300373 Main
1 s2.0 S0923250819300373 Main
Research in Microbiology
journal homepage: www.elsevier.com/locate/resmic
In Memoriam
https://doi.org/10.1016/j.resmic.2019.04.001
0923-2508
118 In Memoriam / Research in Microbiology 170 (2019) 117e120
In 1957, having received an invitation to attend a Symposium of Work with the lactose system uncovered seemingly contradic-
the Society for Experimental Biology in London, she was lucky tory complementation results concerning lacZ, the gene encoding
enough to obtain a passport, and even a French visa. So, she left b-galactosidase. Although there was strong genetic and biochem-
for Paris and managed to meet the famous Dr. Monod who had ical evidence that the gene was a single cistron, encoding a single
been fighting against Lysenko's theories. This was January 1958. polypeptide chain, enzyme activity could be obtained in strains
Agnes was an attractive 30 years old fair-haired woman. containing one gene copy bearing a deletion at its promoter distal
When Monod asked her what she was doing in Paris, she boldly end and one copy with a mutation at its promoter proximal end.
told him that if he allowed her to work in his lab at Institut Pasteur, Exactly what would be expected if the gene consisted of two cis-
she could extend her stay to six weeks. The next morning, she trons. Agnes had a major contribution in solving this apparent
started working with François Gros on the inhibition of protein syn- contradiction. This unexpected complementation involved nonco-
thesis by chloramphenicol. Her collaboration with François Gros valent association between peptides corresponding to different
developed into a close friendship, which would last all of her life. fragments of the wild-type chain.
One day, she confided to him that she wanted to leave Hungary While this first example of intracistronic complementation,
for good, come to France, and go on working forever in the labora- then called u-complementation, had been observed using genes
tory. François Gros advised her to discuss this problem with Monod deleted in the distal part, Agnes wondered whether other combina-
but, since she did not dare to do it, he did it for her. The next day tions of deletion mutants would generate an active enzyme. And
Jacques Monod invited her for dinner at his home. After a few hours she found that when extracts from strains carrying partial deletions
during which she recounted what had happened during the revo- of the promoter proximal segment of lacZ were mixed with extracts
lution, the unending menace of persecution under which Hungar- of b-galactosidase-negative mutants whose promoter-proximal
ians were living, constantly fearing for their security, Jacques segments were intact, she recovered enzymatic activity. There
Monod told her that he was willing to do everything in his power again, she concluded that a peptide encoded by the proximal part
to help her. When she asked him why, he simply answered: “It is of the gene can combine with the rest of the polypeptide to form
a matter of human dignity.” an active enzyme (so-called a-complementation). When the crystal
Back in Budapest, taking advantage of the techniques she had structure of b-galactosidase was published many years later, Agnes
learnt from François Gros, she decided to study, together with her was delighted to find that her original hypothesis based on
husband, Tom Erdo €s, a former student of Szent-Gyo€ rgyi, the mech- biochemical and genetic experiments had been fully confirmed.
anism of action of streptomycin. Working with streptomycin- Today, a-complementation has become the basis for the commonly
sensitive, resistant and dependent strains of Mycobacterium fribur- used “blue/white screen” to identify recombinant DNA: insertion of
giensis, they were able to show, for the first time, that streptomycin foreign DNA into the plasmid-borne proximal part of lacZ results in
inhibits protein synthesis. the abolition of a-complementation and, therefore, of the ability of
Meanwhile, Monod had not forgotten his promise. And he orga- the recombinant cells to hydrolyze the dye XGal.
nized the escape of Agnes and her husband, aboard a trailer pulled In 1961, once the historical paper on “Genetic regulatory mech-
by the car of an “Austrian tourist”. “Our escape, she wrote, was anisms in the synthesis of proteins” had been published, Monod
scheduled for a Saturday in June 1960. The trailer arrived as became interested in another type of regulation, that which gov-
planned and we crammed ourselves under a bathtub. At the border, erns the activity of enzymes. How compounds bearing no structural
two customs officers searched every corner of the vehicle with a similarity with the enzyme substrate could activate or inhibit this
flashlight for more than one hour. It was an absolute miracle that enzyme? This was to be the great period of “allostery”. There again,
they did not catch us. The officers finally left the trailer and, after Agnes took her part, working on rabbit muscle phosphorylase b, an
a few more controls, we were allowed to proceed.” enzyme activated by 50 -AMP. She contributed in showing that in
Once in Paris, Agnes went to work in Monod's laboratory, while the presence of 50 -AMP, phosphorylase b undergoes a reversible
her husband Tom worked at a research institute outside of Paris. conformational change that increases its capacity to bind certain li-
Monod was then working on the regulation of the synthesis of pro- gands. This was to be the basis of the allosteric model: activators or
teins involved in lactose metabolism in Escherichia coli. The operon inhibitors, binding to a site different from the catalytic site, stabilize
model was taking shape, and it involved the participation of a the enzyme in a new conformation.
repressor, preventing the synthesis of the proteins in the absence When Monod was appointed professor at the Colle ge de France,
of lactose. The first project given by Monod to Agnes was the isola- in 1967, he asked Agnes to give a seminar. She chose to talk about a
tion of this repressor, then believed to be an RNA. Not surprisingly, cascade of covalent regulations occurring in the muscle and in
she was not successful, first because the repressor turned out to be which 30 ,50 -cyclic adenosine monophosphate (cAMP) plays the
a protein, and, second, because she lacked a strain overproducing role of a second messenger which activates a cAMP-dependent pro-
the repressor, as did Wally Gilbert and Benno Müller-Hill, who iso- tein kinase. When she read a paper by Makman and Sutherland1
lated it a few years later. describing the presence of cAMP in bacteria, she decided to look
According to the model, the transcription of genes in an for covalent modifications in E. coli triggered by cAMP. This, she
operon starts at a DNA sequence called the promoter, overlapping did not find, but instead she soon found evidence that cAMP was
or close to another sequence, the operator, corresponding to the an allosteric effector involved in the regulation of transcription.
repressor binding site. Therefore, if one could join structural From her results and those of others, it was found that, by binding
genes of one operon to the promoter/operator sequences of to CAP (the catabolite gene activator protein, its receptor protein),
another, this would result in the subordination of those structural cAMP exerts a positive regulation on the otherwise negatively regu-
genes to the regulatory mechanism of the other operon. This is lated lac operon. For 18 years, Agnes worked on the role of cAMP in
what François Jacob and Agnes Ullmann succeeded to do, in the regulatory mechanisms in bacteria, and with her collaborators, -
end of 1963, by obtaining and analyzing mutants carrying dele- because by then she had her own group - she published approxi-
tions that fused genes from the lactose operon to the promoter mately 50 papers on the subject.
of an operon involved in the synthesis of purines. These experi-
ments represented the first example of in vivo genetic engineer-
ing. Gene fusions were to become a major tool to study genetic 1
Makman R.S Sutherland EW (1965) Adenosine 30 ,50 -Phosphate in Escherichia
analysis and regulation. Coli J. Biol. Chem. 240:1309e14.
In Memoriam / Research in Microbiology 170 (2019) 117e120 119
In the early 1980s, with the collaboration of Antoine Danchin, experiments are not more important than that of others ». Together
Agnes started to study the enzyme producing cAMP, adenylate with the regretted Ce cile Wandersman, they were for decades the
cyclase. Danchin cloned the E. coli gene for this enzyme, cyaA, pillars of the “Journal club de Microbiologie”, where many of the
and prepared a gene fusion with lacZ, encoding a hybrid protein young scientists and postdocs from the institute had a chance to
endowed with both enzymatic activities. Agnes, using a one-step calibrate their critical mind on theirs.
purification procedure that she had devised for b-galactosidase, pu- She was also devoted to teaching and organizing courses at the
rified this hybrid protein. This allowed them to perform a structure/ institute as well as in Greece, Brazil or India. She was always
function study of adenylate cyclase. engaged in the support of brilliant young scientists, for instance
Having spent many years on the role of cAMP in E. coli, she by presiding from its beginning, in 1979, the scientific committee
decided to switch to a different area, i.e., study the role of this of a “Jacques Monod Foundation” that gave each year one or two
nucleotide in pathogenesis. prizes to young scientists. By the way, presiding this committee
Upon reviewing the relevant literature, she discovered reports was one of the many ways in which she paid homage to the mem-
on the existence in Bordetella pertussis, the etiologic agent of ory of Jacques Monod, who died in 1976, and for whom she had a
whooping cough, of an adenylate cyclase that exhibited two strik- profound devotion.
ing properties: (i) it was secreted into the extracellular space This devotion, she expressed in many ways. Soon after Monod's
(only intracellular adenylate cyclases were known at that time) death, she co-edited with Andre Lwoff “Selected papers in molecular
and (ii) it was activated by calmodulin, a eukaryotic protein. This biology by Jacques Monod, as well as, “Origins of Molecular Biology. A
enzyme was soon demonstrated to act as a toxin able to invade an- tribute to Jacques Monod” ” with accounts from many scientists who
imal cells where, upon activation by calmodulin, it elicits an unreg- had worked with or close to him both at Academic Press Inc. (1978
ulated increase in cAMP, thereby disrupting normal cellular and 1979, respectively). In 2003, she obtained the publication of a
functions. The study of this fascinating protein then became a major revised edition of the second of these books by ASM Press. A
endeavour, implying both Agnes' group in close collaboration with more personal expression of this devotion was the care she took
the team of A. Danchin as well as several external collaborations, of Monod's Airedale that she brought with her to the lab
some within a Human Frontier Science Program (HFSP) entitled everyday… even though dogs were, in principle, not allowed in
“Molecular and Cellular Mechanisms Underlying Regulation of the institute.
Virulence Factors of B. pertussis” coordinated by her. Analysis of During her career Agnes also organized numerous scientific
the protein, CyaA, and its gene revealed that the amino-terminal meetings including a prestigious celebration of the Centennial of
end of the protein bears the calmodulin activated catalytic activity the Institut Pasteur in 1987, and another one for the 100th anniver-
whereas the carboxy-terminal exhibits strong homology to the E. sary of Louis Pasteur death in 1995.
coli hemolysin. The latter is responsible for the binding of the toxin From 1982 to 1995, under the directorship of Raymond
to eukaryotic cells, and for its internalization. Studies of the genetic Dedonder and then of Maxime Schwartz, she was part of the direc-
organization of the cya locus revealed the presence, downstream to tion of Institut Pasteur, in charge of the applications of research.
the adenylate cyclase structural gene (cyaA), of three additional One of her feat in this function has been the setting up of a “com-
genes (cyaB, cyaD, and cyaE) that build a type I ATP-Binding mando”, headed by Simon Wain-Hobson, to sequence the HIV
Cassette (ABC) secretion machinery dedicated to the secretion of genome. They came first, before the American competitors, and
the toxin. Agnes later got interested in deciphering the transcrip- this was important for the patents in this domain.
tional regulation of the cya operon by a two-component regulatory Her devotion for science included a determination to avoid
system (BvgA/BvgS) that controls the expression of the virulent excess spending of research money. She was not of the kind to
genes of B. pertussis. travel business class, take taxis when not obligatory, ask for reim-
An important development of this study has been the use of bursement of expensive meals or hotels, etc.
adenylate cyclase as a vector to deliver specific epitopes into anti- One of her most obvious qualities was courage. Courage during
gen presenting cells. Indeed, several permissive sites were found her youth, when she opposed the soviet regime in her country.
in the gene where the insertion of a few codons would not impair Courage when she escaped from Hungary. Even courage during
any of the properties of the protein. Further work demonstrated the last months of her life, when she was alone, almost blind,
that such recombinant toxins represented an attractive non- with great difficulties to breathe, and who, when you visited her,
replicative vector for antigen delivery and could be used for the only asked questions about you and your family. Another hallmark
development of protective and therapeutic vaccines. After her of her personality was a genuine curiosity she kept intact up to her
mandatory retirement in 1995, Agnes continued to closely follow very last days: “what's new, in the lab, in “Pasteur”, in science, etc.
the development of this project that lead to the design of two re- ?” were her favorite words when one would call or visit her. She
combinant vaccines that went into phase I/II clinical trials in cancer enjoyed discussing about recently published articles or ongoing ex-
immunotherapy. periments. And despite being confined in her apartment she was
A mere examination of her research activity fails to give full still eagerly interested in what was going on in the world, in her
credit to the extraordinary personality of Agnes Ullmann. Her pas- countries e of origin and of adoption e and in her true “home”, l’In-
sion for science was testified, for instance by her assiduity to sem- stitut Pasteur.
inars, to which she always participated actively as long as she could Agnes Ullmann was both a member of the CNRS (1962e1992)
come to Institut Pasteur, until the very end of 2016. Despite severe and of Institut Pasteur (1978e1996). She published 180 scientific
health problems - she was progressively losing her sight due to a articles, edited or coedited 6 books, and cosigned 5 patents. Aside
Macular Degeneration and suffered from hard back pain and had from several French decorations, including the Legion of Honor,
difficulty to breathe - Agnes was still coming several days a week she received the Robert Koch medal (Germany), was Doctor Hono-
to Institut Pasteur where she had a small office. And she was ris Causa of the Sapienza University in Rome, was a member of
constantly reminding young - or even less young - researchers to EMBO, of the Hungarian Science Academy and of the European
attend seminars, and to those who would argue that they could Microbiology Academy. Finally, in 1966, she had obtained French
not as they had experiments ongoing, she would answer: « your citizenship, something she was very proud of.
120 In Memoriam / Research in Microbiology 170 (2019) 117e120
Agnes was a woman of great culture in the authentic tradi- Daniel Ladant
tion of the “Mitteleuropa”. Over the last seven decades, she Unit
e de Biochimie des Interactions Macromoleculaires, Institut
enjoyed working and interacting with many great scientists in Pasteur, CNRS, Paris, France
many countries. She had witnessed and contributed to the birth
Didier Mazel*
and development of modern biology. She also liked to recall that
Unit
e de Plasticit
e du G
enome Bact
erien, Institut Pasteur, CNRS, Paris,
she had known an era “before DNA”, a time when to perform an
France
experiment, she had first to purify ATP from rabbit muscle, and
she was kindly making fun of the present day “kit generation”. Maxime Schwartz
She died on February 25, 2019. Direction de la Communication, Institut Pasteur, Paris, France
It has been a privilege for us to have been students, colleagues
and friends of this Great Lady. *
Corresponding author.
E-mail address: didier.mazel@pasteur.fr (D. Mazel).
Conflict of interest
10 April 2019
None. Available online 15 May 2019